FDA Inspection 993516 — Central Pennsylvania Blood Bank
The FDA completed an inspection of Central Pennsylvania Blood Bank on Oct 27, 2016 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)